Social media marketing lures people to South Florida’s lucrative cosmetic surgery scene with the promise of cheap Brazilian butt lifts. But some researchers, patient advocates, and surgeon groups say that the risks of the procedure are generally not understood by prospective patients, and that an unsafe number of surgeries can be performed per day in office settings, maximizing profits.
With Medicare and Social Security apparently off the table for federal budget cuts, the focus has turned to Medicaid, the federal-state health program for those with low incomes. President Joe Biden has made it clear he wants to protect the program, along with the Affordable Care Act, but Republicans will likely propose cuts to both […]
Eli Lilly’s news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.
Medi-Cal serves more than one-third of the state’s population — offering a dizzying range of care to a diverse population. In the new “Faces of Medi-Cal” series, California Healthline will assess the program’s strengths and weaknesses through the lives and experiences of its enrollees.
A dental device called AGGA has been used on about 10,000 patients without FDA approval or proof that it works. In lawsuits, patients report irreparable harm. The AGGA’s inventor and manufacturer have denied all liability in court.
California has enrolled into Medi-Cal more than 300,000 older immigrant adults lacking legal residency since May, but the state doesn’t know how many more might be eligible. Community workers are now searching for them.
KHN gives readers a chance to comment on a recent batch of stories.
Programs assisting people with dementia — and their caregivers — improve quality of life and care. But millions of unpaid family and friend caregivers may not know where or how to find help.
“What happens in Texas doesn’t stay in Texas,” warns an abortion rights advocate bracing for a district judge’s ruling on whether the abortion pill mifepristone was properly authorized by the FDA. His decision could force the medication off the U.S. market.
Lawmakers are considering creating standards to set Medicaid reimbursement rates. But industry observers wonder whether the move would be too little, too late to bolster a beleaguered industry.
